We are live on
!
Find out more
LCM
Laurion Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
75.73%
This Fund
S&P 500
This Quarter
Est. Return
-12.52%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$6.47B
AUM Growth
-$1.7B
(-21%)
Cap. Flow
-$612M
Cap. Flow
% of AUM
-9.46%
Top 10 Holdings %
Top 10 Hldgs %
39.4%
Holding
758
New
244
Increased
84
Reduced
79
Closed
303
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$69.4M |
| 2 |
Morgan Stanley
MS
|
+$50.7M |
| 3 |
Citigroup
C
|
+$50.1M |
| 4 |
Amazon
AMZN
|
+$49.8M |
| 5 |
Warner Bros
WBD
|
+$42.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Flavors & Fragrances
IFF
|
+$284M |
| 2 |
T-Mobile US
TMUS
|
+$161M |
| 3 |
Qualcomm
QCOM
|
+$151M |
| 4 |
Micron Technology
MU
|
+$149M |
| 5 |
Alibaba
BABA
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.55% |
| 2 | Communication Services | 6.92% |
| 3 | Consumer Discretionary | 5.57% |
| 4 | Utilities | 3.44% |
| 5 | Financials | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKUS
226
DELISTED
Akouos Inc
AKUS
| $2.14M | 0.03% |
+456,000
| New | +$1.61M |
|
227
Shattuck Labs
STTK
$682M
| $2.05M | 0.03% |
+506,000
| New | +$1.83M |
|
|
CMPS
228
Compass Pathways
CMPS
$1.78B
| $2.05M | 0.03% |
189,407
| – | – |
|
229
Olema Pharmaceuticals
OLMA
$1.04B
| $2.02M | 0.03% |
+495,300
| New | +$1.57M |
|
230
Mastercard
MA
$493B
| $2M | 0.03% |
6,328
-20,675
| -77% | -$7.12M |
|
231
Tenet Healthcare
THC
$20.9B
| $1.97M | 0.03% |
+37,428
| New | +$2.6M |
|
|
TWTR
232
PUT
DELISTED
Twitter, Inc.
TWTR
| $1.87M | 0.03% |
+50,000
| New | +$2.15M |
|
233
Ovintiv
OVV
$17.6B
| $1.77M | 0.03% |
+40,037
| New | +$2.06M |
|
|
RAIN
234
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $1.74M | 0.03% |
+313,200
| New | +$1.08M |
|
235
Coherent
COHR
$63.6B
| $1.74M | 0.03% |
+34,126
| New | +$2.08M |
|
236
Las Vegas Sands
LVS
$29.4B
| $1.73M | 0.03% |
51,591
-1,209,572
| -96% | -$41.9M |
|
237
4D Molecular Therapeutics
FDMT
$582M
| $1.71M | 0.03% |
245,123
| – | – |
|
238
Advanced Micro Devices
AMD
$767B
| $1.69M | 0.03% |
22,150
-51,900
| -70% | -$4.86M |
|
239
Analog Devices
ADI
$187B
| $1.69M | 0.03% |
11,552
-557,848
| -98% | -$87.8M |
|
240
Home BancShares
HOMB
$6.17B
| $1.67M | 0.03% |
+80,302
| New | +$1.74M |
|
241
Berkshire Hathaway Class B
BRK.B
$1.13T
| $1.66M | 0.03% |
+6,061
| New | +$1.9M |
|
242
Taysha Gene Therapies
TSHA
$1.83B
| $1.65M | 0.03% |
+442,600
| New | +$1.76M |
|
|
OMGA
243
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $1.64M | 0.03% |
+432,700
| New | +$1.61M |
|
244
Wynn Resorts
WYNN
$10.6B
| $1.63M | 0.03% |
+28,525
| New | +$1.89M |
|
245
Cardiff Oncology
CRDF
$80.1M
| $1.59M | 0.02% |
+722,100
| New | +$1.21M |
|
|
LENZ
246
LENZ Therapeutics
LENZ
$168M
| $1.58M | 0.02% |
+81,943
| New | +$1.83M |
|
247
Entrada Therapeutics
TRDA
$271M
| $1.57M | 0.02% |
+129,066
| New | +$979K |
|
|
LITS
248
Lite Strategy Inc
LITS
$29.6M
| $1.56M | 0.02% |
+128,845
| New | +$1.4M |
|
249
CALL
AutoZone
AZO
$50.1B
| $1.5M | 0.02% |
+700
| New | +$1.44M |
|
|
IACC
250
DELISTED
ION Acquisition Corp 3 Ltd.
IACC
| $1.46M | 0.02% |
150,000
| – | – |
|
Similar funds
AFM
GCP
LCM
MAP
MA
NSAM
ABI
OCM
Laurion Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Laurion Capital Management held 758 positions worth $6.47B, down 21% from $8.17B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Laurion Capital Management withdrew a net $612M in Q2 2022, closing 303 positions and reducing 79 holdings. Its most notable exit was International Flavors & Fragrances, an estimated $284M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Laurion Capital Management opened a new position in Morgan Stanley worth $47M.
- Laurion Capital Management's largest Q2 2022 buy was Morgan Stanley: 618,580 shares worth $47M.
- Laurion Capital Management added most to Lowe's Companies in Q2 2022, an estimated $69.4M increase.
- Laurion Capital Management's biggest Q2 2022 reduction was T-Mobile US, cutting an estimated $161M.
- Laurion Capital Management fully exited International Flavors & Fragrances in Q2 2022, selling an estimated $284M.
- Laurion Capital Management's ten largest holdings make up 39% of its $6.47B portfolio in Q2 2022.
- Laurion Capital Management opened 244 new positions and closed 303 in Q2 2022.
- Laurion Capital Management's portfolio value fell 21% quarter-over-quarter to $6.47B.
Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.